Ye, Yang-liang <br/><br/>
Discovery of novel dual functional agent as PPARgamma agonist and 11beta-HSD1 inhibitor for the treatment of diabetes.  [electronic resource] 

 -  Bioorganic & medicinal chemistry  Aug 2009 
 - 5722-32 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1464-3391 
<br/><br/><label>Standard No.: </label>10.1016/j.bmc.2009.05.082  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>11-beta-Hydroxysteroid Dehydrogenase Type 1--antagonists & inhibitors<br/>Animals<br/>Body Weight--drug effects<br/>Diabetes Mellitus, Experimental--drug therapy<br/>Fats--metabolism<br/>Humans<br/>Hypoglycemic Agents--chemistry<br/>Hypolipidemic Agents--chemistry<br/>Mice<br/>Models, Molecular<br/>Obesity--chemically induced<br/>PPAR gamma--agonists<br/>Phenylpropionates--chemistry<br/>Rats<br/>Rats, Wistar